Machine learning to detect melanoma exploiting nuclei morphology and Spatial organization.

Publication date: Jul 01, 2025

Cutaneous melanoma is one of the most lethal forms of skin cancer, and its incidence is increasing globally. Its diagnosis typically relies on manual histopathological examination, a process that is both complex and time consuming. In this study, we propose an automated diagnostic tool, capable of generating interpretable results to aid clinical decision-making. A total of 146 whole slide images are included in the study, encompassing various lesion types: congenital nevi, dysplastic nevi, melanomas, and melanomas on nevi. The images were first processed using a multi-resolution image processing pipeline with the aim of segmenting nuclei, evaluating their geometrical and morphological features, as well as their spatial organization. To characterize each slide, these features were synthesized into 44 variables, which were then subjected to Linear Discriminant Analysis. Through this procedure, 18 relevant variables were identified demonstrating good performance in melanoma detection, as validated through Monte Carlo Cross-Validation. These variables were also interpreted within the framework of established histopathological diagnostic insights. By refining the analysis to the cellular level, we emulated standard clinical evaluation practices, ensuring that every aspect of the diagnostic process was accessible and verifiable by medical professionals. The proposed tool can offers significant potential to support clinicians in various tasks, such as prioritizing the analysis of critical samples and providing a secondary diagnostic opinion in complex cases.

Open Access PDF

Concepts Keywords
Cancer Cell Nucleus
Clinicians Histopathology
Histopathological Humans
Increasing Image Processing, Computer-Assisted
Slide Machine aided diagnosis
Machine Learning
Machine learning
Melanoma
Melanoma
Skin Neoplasms
Spatial statistics

Semantics

Type Source Name
disease MESH melanoma
pathway KEGG Melanoma
disease MESH skin cancer
disease MESH nevi dysplastic
disease MESH nevi
drug DRUGBANK Gold
disease MESH neoplasms
disease MESH overdiagnosis
drug DRUGBANK Coenzyme M
pathway REACTOME Translation
disease MESH recurrence
drug DRUGBANK Resiniferatoxin
drug DRUGBANK Pidolic Acid
disease MESH confusion
drug DRUGBANK MCC
drug DRUGBANK Bismuth subgallate
disease MESH cutaneous malignant melanoma
disease MESH uveal melanoma
disease MESH NonSmall Cell lung Cancer
disease MESH breast cancer
pathway KEGG Breast cancer
disease MESH inflammation
disease MESH metastasis
disease MESH death
disease MESH carcinomas
disease MESH mesothelioma
disease MESH squamous carcinoma
disease MESH primary brain tumors
drug DRUGBANK Serine
disease MESH pathogenesis
pathway REACTOME Reproduction

Original Article

(Visited 9 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *